IF calcium alpha-ketoglutarate (CaAKG, 2% w/w in chow, initiated at 18 months of age) is administered to aged C57BL/6J female and male mice for 12 weeks, and if a parallel cohort of age-matched, hematopoietic-conditional TET2-knockout (TET2-cKO; Mx1-Cre) mice receives the identical protocol,

THEN CaAKG-treated wild-type aged mice will exhibit a ≥15% reduction in DNA methylation β-values at the three validated age-hypermethylated clock CpG loci — Prima1, Hsf4, and Kcns1 — as quantified by bisulfite pyrosequencing and corroborated by RRBS; a statistically significant reduction in biological age as estimated by both the 3-CpG murine epigenetic clock and the blood-based DNAmPhenoAge predictor; and this epigenetic clock reversal will be selectively abrogated (≤3% demethylation, non-significant clock shift) in the TET2-cKO cohort receiving identical CaAKG supplementation, thereby causally isolating TET2-mediated demethylation as the essential mechanism rather than metabolic or mTOR-dependent pathways,

BECAUSE the following mechanistic chain operates:

1. Systemic and tissue-level αKG concentrations decline progressively and significantly with age in mammalian tissues, reducing the bioavailability of the obligate cofactor for TET dioxygenases. (Age-associated changes in αKG and TET activity in mammalian tissues — established in the literature review of the Evidence Set, citing Asadi Shahmirzadi et al., Cell Metabolism.)
2. TET1, TET2, and TET3 require αKG, Fe(II), and O₂ as co-substrates to iteratively oxidize 5-methylcytosine (5mC) → 5-hydroxymethylcytosine (5hmC) → 5-formylcytosine (5fC) → 5-carboxylcytosine (5caC); the 5fC/5caC oxidation products are excised by thymine DNA glycosylase (TDG) and replaced by unmethylated cytosine via base excision repair, constituting true active demethylation of already-accumulated methylation marks. (Biochemistry section of the Evidence Set, citing Tahiliani et al., Science, 2009.)
3. Age-dependent TET2 activity specifically declines in the hematopoietic compartment — the tissue source for blood-based epigenetic clocks — contributing to stem cell exhaustion and myeloid skewing, making blood an ideal tissue for testing TET2-dependent demethylation by CaAKG. (Evidence Set, hematopoietic TET2 decline section, citing Moran-Crusio et al.)
4. The Prima1, Hsf4, and Kcns1 CpG sites define a validated murine epigenetic clock that accurately estimates chronological age in blood with performance comparable to multi-hundred-CpG clocks, making them mechanistically tractable single-locus targets for bisulfite pyrosequencing readout; their progressive hypermethylation represents already-accumulated epigenetic damage with functional downstream consequences. (Epigenetic age-predictor for mice based on three CpG sites)[https://doi.org/10.7554/elife.37462.001]
5. A 90-CpG blood-based murine epigenetic clock has been validated that detects biological age differences across longevity interventions in C57BL/6 mice, providing a multi...

SENS category: OncoSENS

Key references: • doi.org/10.7554/elife.37462.001] • doi.org/10.1016/j.cmet.2017.03.016] • doi.org/10.1101/gr.240093.118] • doi.org/10.1101/2025.04.30.651114] • doi.org/10.7554/elife.37462.001];